Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 11, 2011 - Issue 5
Submit an article Journal homepage
29
Views
6
CrossRef citations to date
0
Altmetric
Theme: Neurologic - Editorial

Clinical end points in recurrent glioblastoma: are antiangiogenic agents friend or foe?

Enrico Franceschi Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL, Bologna, Italy
&
Alba A Brandes Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL, Bologna, Italy. [email protected]
Pages 657-660 | Published online: 10 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Richard C Curry, Saurabh Dahiya, Vyshak Alva Venur, Jeffrey J Raizer & Manmeet S Ahluwalia. (2015) Bevacizumab in high-grade gliomas: past, present, and future. Expert Review of Anticancer Therapy 15:4, pages 387-397.
Read now
Jessie M Wu & Carolyn A Staton. (2012) Anti-angiogenic drug discovery: lessons from the past and thoughts for the future. Expert Opinion on Drug Discovery 7:8, pages 723-743.
Read now

Articles from other publishers (4)

Wonsuk Yoo, Seongho Kim, Michael Garcia, Shwetal Mehta & Nader Sanai. (2022) Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review. BMC Medical Research Methodology 22:1.
Crossref
Veronica Villani, Alessandra Fabi, Antonio Tanzilli, Francesco Pasqualetti, Giuseppe Lombardi, Antonello Vidiri, Alessandra Gonnelli, Alessandro Molinari, Martina Cantarella, Luisa Bellu, Irene Terrenato, Mariantonia Carosi, Marta Maschio, Stefano Maria Telera, Carmine Maria Carapella, Francesco Cognetti, Fabiola Paiar, Vittorina Zagonel & Andrea Pace. (2019) A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: clinical benefit is a plausible end point?. Future Oncology 15:15, pages 1717-1727.
Crossref
Daniel T. Nagasawa, Christina Fong, Andrew Yew, Marko Spasic, Heather M. Garcia, Carol A. Kruse & Isaac Yang. (2012) Passive Immunotherapeutic Strategies for the Treatment of Malignant Gliomas. Neurosurgery Clinics of North America 23:3, pages 481-495.
Crossref
Daniel T. Nagasawa, Frances Chow, Andrew Yew, Won Kim, Nicole Cremer & Isaac Yang. (2012) Temozolomide and Other Potential Agents for the Treatment of Glioblastoma Multiforme. Neurosurgery Clinics of North America 23:2, pages 307-322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.